Based upon extensive experimental evidence showing that the inhibition of AR prevents or delays hyperglycemic injury in several experimental models of diabetes, it has been suggested that AR is one of the main mediators of secondary diabetic complications [135,136,137,138,139,140,141]. The gene discussed is AR; the disease is diabetes mellitus.